ATTAPHOL PAWARODE

ATTAPHOL PAWARODE

University of Michigan

H-index: 29

North America-United States

About ATTAPHOL PAWARODE

ATTAPHOL PAWARODE, With an exceptional h-index of 29 and a recent h-index of 25 (since 2020), a distinguished researcher at University of Michigan, specializes in the field of Blood and Marrow Transplantation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Amphiregulin, ST2, and REG3α Biomarker Risk Algorithms as Predictors of Non-Relapse Mortality in Patients with Acute GVHD

Incidence of Restrictive Lung Disease Following Autologous Stem Cell Transplantation for High Risk Lymphoma

Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation to Mitigate Acute Graft Versus …

A phase 2 trial of CD24Fc for prevention of graft-versus-host disease

Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk Score

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients

Cardiovascular events after hematopoietic stem cell transplant: incidence and risk factors

ATTAPHOL PAWARODE Information

University

Position

Assistant Professor of Internal Medicine

Citations(all)

3222

Citations(since 2020)

2016

Cited By

1992

hIndex(all)

29

hIndex(since 2020)

25

i10Index(all)

53

i10Index(since 2020)

42

Email

University Profile Page

Google Scholar

ATTAPHOL PAWARODE Skills & Research Interests

Blood and Marrow Transplantation

Top articles of ATTAPHOL PAWARODE

Amphiregulin, ST2, and REG3α Biomarker Risk Algorithms as Predictors of Non-Relapse Mortality in Patients with Acute GVHD

Blood Advances

2024/4/23

Incidence of Restrictive Lung Disease Following Autologous Stem Cell Transplantation for High Risk Lymphoma

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation to Mitigate Acute Graft Versus …

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

A phase 2 trial of CD24Fc for prevention of graft-versus-host disease

Blood

2024/1/4

Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk Score

Journal of the American Heart Association

2024/1/2

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

Leukemia

2023/5

Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients

Bone Marrow Transplantation

2023/4

Monalisa Ghosh
Monalisa Ghosh

H-Index: 6

Attaphol Pawarode
Attaphol Pawarode

H-Index: 22

Cardiovascular events after hematopoietic stem cell transplant: incidence and risk factors

Cardio Oncology

2023/12/1

Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation

Nature Medicine

2023/11

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

Blood advances

2023/8/8

Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

Blood advances

2023/6/27

Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

Blood Advances

2022/6/28

Outcomes of allogeneic hematopoietic cell transplantation in T cell prolymphocytic leukemia: a Contemporary analysis from the Center for International Blood and Marrow …

Transplantation and cellular therapy

2022/4/1

Relapse and disease-free survival in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation using older matched sibling donors vs …

JAMA oncology

2022/3/1

Myeloablative conditioning for allogeneic transplantation results in superior disease-free survival for acute myelogenous leukemia and myelodysplastic syndromes with low …

Transplantation and cellular therapy

2021/1/1

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation

Blood advances

2021/12/14

Outcomes and utilization trends of front-line autologous hematopoietic cell transplantation for mantle cell lymphoma

Transplantation and cellular therapy

2021/11/1

Fludarabine and melphalan compared with reduced doses of busulfan and fludarabine improve transplantation outcomes in older patients with myelodysplastic syndromes

Transplantation and cellular therapy

2021/11/1

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by …

haematologica

2021/8/1

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia

2021/6

See List of Professors in ATTAPHOL PAWARODE University(University of Michigan)